Unadjusted (N=635 710) | Adjusted* (N=618 154) | |||
---|---|---|---|---|
1-Month survival rate | OR (95% CI) | p Value | Adjusted OR (95% CI) | p Value |
Tertile of prefecture-level health expenditure per capita | ||||
Low | Ref | Ref | ||
Medium | 1.31 (1.02 to 1.67) | 0.03 | 1.31 (1.03 to 1.66) | 0.03 |
High | 1.30 (1.04 to 1.62) | 0.02 | 1.30 (1.03 to 1.64) | 0.02 |
Favourable neurological outcome at 1 month | Unadjusted (N=635 046) | Adjusted* (N=617 490) | ||
OR (95% CI) | p Value | Adjusted OR (95% CI) | p Value | |
Tertile of prefecture-level health expenditure per capita | ||||
Low | Ref | Ref | ||
Medium | 1.30 (1.02 to 1.67) | 0.04 | 1.29 (1.03 to 1.62) | 0.03 |
High | 1.26 (1.04 to 1.53) | 0.02 | 1.28 (1.06 to 1.55) | 0.01 |
*Adjusted for age, sex, the interaction between age and sex, year indicators, aetiology of arrest (cardiac vs non-cardiac), initial cardiac rhythm (VF or pulseless VT), witness status, CPR by bystander and use of public-access AED by bystander.
AED, automated external defibrillator; CPR, cardiopulmonary resuscitation; VF, ventricular fibrillation; VT, ventricular tachycardia.